RELATED CONTENT
NEWS
- US FDA probes cardio events, deaths in Sanofi halted Multaq study
- FDA: Sanofi's Multaq increased risk of cardio events, death in Afib patients
- CHMP opines positively on Dificlir, hypertension and diabetes combos, but restricts Multaq
- Sanofi Multaq worries persuaded Merck to pull oral AF drug and cause Cardiome arrest
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK

Section Head (m/f)
DRA International/CIS Section

Section Head (m/f)
DRA International/CIS Section

